Associated Papers
Mice lacking global Stap1 expression do not manifest hypercholesterolemia.
Kanuri B et al.
Bmc Medical Genetics, 2020
Taking One Step Back in Familial Hypercholesterolemia: STAP1 Does Not Alter Plasma LDL (Low-Density Lipoprotein) Cholesterol in Mice and Humans.
Loaiza N et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2020
Predicted pathogenic mutations in STAP1 are not associated with clinically defined familial hypercholesterolemia.
Lamiquiz-Moneo I et al.
Atherosclerosis, 2020
PCSK9 Variants in Familial Hypercholesterolemia: A Comprehensive Synopsis.
Guo Q et al.
Frontiers in Genetics, 2020
Genes Potentially Associated with Familial Hypercholesterolemia.
Mikhailova S et al.
Biomolecules, 2019
Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia.
Fouchier SW et al.
Circulation Research, 2014
FH4=STAP1. Another gene for familial hypercholesterolemia? Relevance to cascade testing and drug development?
Day IN
Circulation Research, 2014
Select a paper to view details